Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Eden Research (9T7) Stock Price & Analysis

0 Followers

9T7 Stock Chart & Stats

€0.03€0.00(0.00%)
At close: 5:30 PM GMT+1
€0.02€0.04€0.06Sep 26Mar 3Jun 19Jan 6Aug 31
Day’s Range
EUR 0.02 - EUR 0.03
52-Week Range
EUR 0.02 - EUR 0.05
Previous Close
EUR 0.03
Volume
N/A
Average Volume (3M)
0
Market Cap
EUR 30.28M
Enterprise Value
EUR 18.76M
Total Cash (Recent Filing)
EUR 1.85M
Total Debt (Recent Filing)
EUR 571.86K
Price to Earnings (P/E)
―
Beta
1.02
Next Earnings
May 11, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Conservative Balance Sheet

Very low leverage and a sizable equity base provide financial resilience while Eden remains loss-making. Limited debt reduces interest and refinancing pressure, preserving greater flexibility to fund product development, regulatory approvals, and commercial expansion over the next several quarters.

Long-term Revenue Growth

The substantial multi-year increase in revenue indicates that Eden has expanded commercial activity and gained traction for its products over time. Although growth has been uneven, this larger revenue base can support operating leverage if partner sales and product adoption continue to develop.

Positive Gross Margin

A positive gross margin shows that Eden’s products generate value above direct product costs before operating expenses. This provides an underlying path toward improved profitability, provided the company can grow sales sufficiently and control overhead while maintaining product economics.

Bears Say

Persistent Operating Losses

Recurring operating and net losses show that Eden has not yet converted commercial activity into sustainable earnings. Continued losses can constrain reinvestment, weaken returns on equity, and require the company to achieve stronger scale or expense discipline before profitability becomes durable.

Recurring Cash Burn

Persistent negative operating and free cash flow means the business is not currently funding operations from internally generated cash. This increases reliance on external financing or available reserves and makes execution of product, regulatory, and commercial plans more financially demanding.

Uneven Growth Without Leverage

The recent revenue pullback and continuing operating losses indicate that top-line expansion has not yet translated into consistent operating leverage. Uneven sales can make planning less predictable and delay the point at which Eden’s gross profit covers its recurring operating cost base.

Eden Research News

9T7 FAQ

What was Eden Research’s price range in the past 12 months?
Eden Research lowest stock price was €0.02 and its highest was €0.05 in the past 12 months.
What is Eden Research’s market cap?
Eden Research’s market cap is €30.28M.
When is Eden Research’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Eden Research’s earnings last quarter?
Eden Research released its earnings results on Sep 17, 2025. The company reported -€0.002 earnings per share for the quarter.
Is Eden Research overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Eden Research pay dividends?
Eden Research does not currently pay dividends.
What is Eden Research’s EPS estimate?
Eden Research’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Eden Research have?
Eden Research has 803,363,000 shares outstanding.
What happened to Eden Research’s price movement after its last earnings report?
Eden Research reported an EPS of -€0.002 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Eden Research?
Currently, no hedge funds are holding shares in DE:9T7
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology